NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/01/2023
Back to search
Official data from USPTO
AABB ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/01/2023
Trademark type
Combined
Nice classes
200
Filing date
10/21/2021
Registration date
08/01/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2023
Last transaction
08/01/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-10-00
First use in commerce
2021-10-00
Drawing code
5
Owner type
03
Owner location
Bethesda, MD, US
Examiner
WHITE, TRAVIS WILLIAM
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of lower case letters "AABB" intertwined and appearing over the words "ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES".
Holders and representatives
Holders
American Association of Blood Banks
Representatives
Cheryl L. Howard CROWELL & MORING LLP
Technical classification
Nice Classes
Class 200
Vienna Codes
No Vienna codes available.
Goods and services
Class 200
Indicating membership in an association of physicians and health care professionals
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/01/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/29/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/12/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/09/2023
IUAF
USE AMENDMENT FILED
05/18/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/18/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2022
GNRT
NON-FINAL ACTION E-MAILED
08/01/2022
CNRT
NON-FINAL ACTION WRITTEN
08/01/2022
DOCK
ASSIGNED TO EXAMINER
07/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2021
NWAP
NEW APPLICATION ENTERED
10/25/2021
Continuous trademark protection
Get notified about every new filing that threatens AABB ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.